Ewing sarcoma of bone (Cancer)
Information
- Disease name
- Ewing sarcoma of bone
- Disease ID
- DOID:3368
- Description
- "A peripheral primitive neuroectodermal tumor that is located_in bone." [url:http\://en.wikipedia.org/wiki/Ewing%27s_sarcoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00618813 | Completed | N/A | Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors | March 2008 | |
NCT05024253 | Completed | Phase 3 | Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. | August 2, 2021 | February 1, 2024 |
NCT00674193 | Completed | Evaluating Dactinomycin and Vincristine in Young Patients With Cancer | February 2008 | ||
NCT00516295 | Completed | Phase 2 | Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma | February 2008 | January 2010 |
NCT01825902 | Completed | Early Phase 1 | 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma | March 2013 | November 23, 2015 |
NCT03968471 | Completed | Chemotherapy-induced Necrosis in Ewing Sarcoma | May 13, 2019 | January 15, 2020 | |
NCT06068075 | Recruiting | N/A | Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD | May 8, 2018 | January 1, 2026 |
NCT04845893 | Recruiting | Observational Study on Skeletal Ewing's Sarcoma | June 1, 2021 | May 25, 2028 | |
NCT05033288 | Recruiting | Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | January 20, 2022 | August 30, 2028 | |
NCT05395741 | Recruiting | Phase 1/Phase 2 | Regorafenib in Patients With Refractory Primary Bone Tumors | April 28, 2022 | December 31, 2025 |
NCT01795430 | Withdrawn | N/A | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma | July 2013 | |
NCT05116800 | Withdrawn | Phase 2 | Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma | March 1, 2022 | August 2030 |
- Disase is a (Disease Ontology)
- DOID:3369
- Cross Reference ID (Disease Ontology)
- NCI:C35871
- Cross Reference ID (Disease Ontology)
- NCI:C4835
- Cross Reference ID (Disease Ontology)
- NCI:C6623
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:307608006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0585474
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1333481
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1334406
- Exact Synonym (Disease Ontology)
- bone Ewing sarcoma
- Exact Synonym (Disease Ontology)
- bone localized Ewing sarcoma
- Exact Synonym (Disease Ontology)
- bone localized Ewing's sarcoma
- Exact Synonym (Disease Ontology)
- Ewing's sarcoma/bone peripheral primitive neuroectodermal tumor
- Exact Synonym (Disease Ontology)
- localized Skeletal Ewing's sarcoma
- Disase Synonym (Disease Ontology)
- bone Ewing's sarcoma
- Disase Synonym (Disease Ontology)
- Ewing's sarcoma of bone